BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World J Cardiol 2020; 12(7): 342-350 [PMID: 32843936 DOI: 10.4330/wjc.v12.i7.342]
URL: https://www.wjgnet.com/1949-8462/full/v12/i7/342.htm
Number Citing Articles
1
Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil. The prothrombotic tendency of metabolic-associated fatty liver diseaseJournal of Thrombosis and Haemostasis 2023; 21(11): 3045 doi: 10.1016/j.jtha.2023.06.017
2
A.Y. Baylo, V.P. Shipulin, V.V. Cherniavskyi, L.M. Parunyan. 1GASTROENTEROLOGY 2021; 55(1): 21 doi: 10.22141/2308-2097.55.1.2021.229432
3
A. G. Komarova, S. A. Bliznyuk, D. S. Lyasina, E. A. Naryshkina, A. V. Bumbu, S. D. Covantsev. Anticoagulant prophylaxis in patients with liver disease and atrial fibrillationMedical alphabet 2024; (3): 17 doi: 10.33667/2078-5631-2024-3-17-22
4
Hongqun Liu, Sang-Youn Hwang, Samuel S. Lee. Role of Galectin in Cardiovascular Conditions including Cirrhotic CardiomyopathyPharmaceuticals 2023; 16(7): 978 doi: 10.3390/ph16070978
5
Adonis A. Protopapas, Christos Savopoulos, Lemonia Skoura, Ioannis Goulis. Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?Digestive Diseases and Sciences 2023; 68(6): 2237 doi: 10.1007/s10620-023-07858-9
6
Sanjana Nagraj, Spyros Peppas, Maria Gabriela Rubianes Guerrero, Damianos G Kokkinidis, Felipe I Contreras-Yametti, Sandhya Murthy, Ulrich P Jorde. Cardiac risk stratification of the liver transplant candidate: A comprehensive reviewWorld Journal of Transplantation 2022; 12(7): 142-156 doi: 10.5500/wjt.v12.i7.142
7
Bert Vandenberk, Mario H. Altieri, Hongqun Liu, Satish R. Raj, Samuel S. Lee. Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertensionAlimentary Pharmacology & Therapeutics 2023; 57(3): 290 doi: 10.1111/apt.17368
8
Xiya Lu, Zhijing Wang, Liu Yang, Changqing Yang, Meiyi Song. Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective StudyFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.704073
9
Irina Gîrleanu, Anca Trifan, Laura Huiban, Cristina Maria Muzica, Oana Cristina Petrea, Ana-Maria Sîngeap, Camelia Cojocariu, Stefan Chiriac, Tudor Cuciureanu, Remus Stafie, Sebastian Zenovia, Ermina Stratina, Adrian Rotaru, Robert Nastasa, Catalin Sfarti, Irina Iuliana Costache, Carol Stanciu. Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?Diagnostics 2023; 13(6): 1160 doi: 10.3390/diagnostics13061160
10
Justin J. Song, Nicholas J. Jackson, Helen Shang, Henry M. Honda, Kristin Boulier. Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes StudyJournal of Cardiovascular Pharmacology and Therapeutics 2024; 29 doi: 10.1177/10742484241256271
11
Tae Hyung Kim, Seung Young Kim, Young Kul Jung, Hyung Joon Yim, Jin-Man Jung, Woo-Keun Seo. FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related strokeClinical Neurology and Neurosurgery 2022; 217: 107235 doi: 10.1016/j.clineuro.2022.107235
12
Sang Youn Hwang, Hongqun Liu, Samuel S. Lee. Dysregulated Calcium Handling in Cirrhotic CardiomyopathyBiomedicines 2023; 11(7): 1895 doi: 10.3390/biomedicines11071895
13
Nelson Barrera, Katerina Jou, Mushrin Malik, Francisco Gallegos‐Koyner, Salomon Chamay, Khaled Elfert, Roberto C. Cerrud‐Rodriguez, Luigi Di Biase. Safety of catheter ablation for atrial fibrillation in patients with liver cirrhosisJournal of Cardiovascular Electrophysiology 2024;  doi: 10.1111/jce.16472